Session 1: Cancer genome sequencing
Go back to the summary of the CRI symposium.Overall summary: The top10 BrCA CaGens only account for 50% of mutation load, the tail is going to be important in personalising treatment. Some patients only show a single driver mutation, can cancer be driven by a […]